Susan Mileham
Psychiatric/Mental Health · Wichita, KSNPI 1134375280
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 529 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 529 payments — averaging $14.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$2K
- Johnson & Johnson$969
- Neos Therapeutics, LP$766
- AbbVie$731
- Axsome Therapeutics, Inc.$524
- Alkermes, Inc.$477
- plus $2K from 17 others
What the payments were for
- Food & beverage$7,53399%
- Education$691%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 123 | $1,784 |
| Johnson & Johnson | 43 | $969 |
| Neos Therapeutics, LP | 89 | $766 |
| AbbVie | 73 | $731 |
| Axsome Therapeutics, Inc. | 21 | $524 |
| Alkermes, Inc. | 27 | $477 |
| Vanda Pharmaceuticals Inc. | 13 | $349 |
| Bausch Health US, LLC | 25 | $282 |
| Lundbeck LLC | 17 | $277 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $251 |
| Corium, LLC | 24 | $214 |
| Supernus Pharmaceuticals, Inc. | 6 | $204 |
| Eisai Inc. | 9 | $187 |
| Teva Pharmaceuticals USA, Inc. | 5 | $116 |
| Sunovion Pharmaceuticals Inc. | 14 | $107 |
| Neurocrine Biosciences, Inc. | 7 | $96 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $95 |
| Collegium Pharmaceutical, Inc. | 4 | $78 |
| Ironshore Pharmaceuticals Inc. | 2 | $32 |
| Tris Pharma Inc | 1 | $19 |
| Avanir Pharmaceuticals, Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,603 in reported general payments places this provider in the 90th percentile of 404 psychiatric/mental health providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 19 | $28,259 |
| QuviviqDaridorexant Hcl | 13 | $7,174 |
| VyvanseLisdexamfetamine Dimesylate | 14 | $5,787 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 30 | $4,909 |
| RitalinMethylphenidate Hcl | 13 | $2,194 |
| Vilazodone Hcl | 12 | $1,760 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 30 | $1,211 |
| Bupropion XlBupropion Hcl | 12 | $837 |
| Alprazolam | 54 | $737 |
| Ziprasidone Hcl | 11 | $348 |
| Escitalopram Oxalate | 45 | $346 |
| Clonazepam | 33 | $294 |
| Buspirone Hcl | 13 | $234 |
| Lorazepam | 25 | $97 |
| Lamotrigine | 12 | $84 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,784 | $28,25919 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $15 | $7,17413 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $251 | $5,78714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 404 psychiatric/mental health providers in Kansas.
Other psychiatric/mental health in Wichita
- Hayley KnappWichita$31K
- Deborah MurphyWichita$13K
- Julius QuinnWichita$10K
- Ashley MeluginWichita$9K
- Jacy BarkerWichita$9K
- Angela TheobaldWichita$6K
- Alyson Taylor-SmithWichita$5K
- Ruth HartWichita$5K
- Julia McVayWichita$5K
- Amy AdamsWichita$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.